News and Announcements
AnaeCo – Approval of Research & Development Tax Incentive Refund of $4.9m
- Published February 21, 2013 4:53PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
AnaeCo confirms that it’s R&D Tax Incentive of $4.9m in respect of the 2012 financial year has been approved.
The R&D Tax Incentive scheme replaced the R&D Tac Concession from 1 July 2011 and the scheme provides for cash refunds in certain circumstances. AnaeCo meets the eligibility criteria for cash payment of the refund, which is calculated as 45% of eligible R&D expenses. AnaeCo’s claim is based on expenditure incurred on development of the DiCOM™ System, which for 2012 amounted to $10.9m. AnaeCo’s expenditure on development of the DiCOM System, in particular through its demonstration at the WMRC DiCOM Expansion Project, has continued in the 2013 financial year and AnaeCo expects to make a further eligible claim for this year.
To read a full ASX announcement, please download the document below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
